Jiangbo Lin

机构：Fujian Medical University · ORCID：0000-0002-5016-3153

发表论文 35 篇 · 总被引 233 次 · h-index 8

代表论文

• Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma (2025 · JAMA Surgery · 被引 71)
• LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma (2020 · Journal of Clinical Laboratory Analysis · 被引 20)
• LncRNA C9orf139 can regulate the progression of esophageal squamous carcinoma by mediating the miR-661/HDAC11 axis (2022 · Translational Oncology · 被引 14)
• Median sternotomy versus minimally invasive thymectomy for early-stage thymoma (2019 · Medicine · 被引 10)
• Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world study (2025 · International Journal of Surgery · 被引 8)
• Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study (2023 · Journal of Thoracic Disease · 被引 7)